JRSS OTC
JRSIS Health Care Corporation
1W: -6.7%
1M: -22.2%
3M: -31.7%
YTD: -22.6%
1Y: +7.7%
3Y: -98.0%
5Y: -98.9%
$0.01
-0.00 (-6.67%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$320K
-75.8% ▼
5Y CAGR: -61.0%
Gross Profit
$56K
-79.6% ▼
5Y CAGR: -69.3%
Operating Income
$8K
+101.7% ▲
5Y CAGR: -72.9%
Net Income
$9K
+101.7% ▲
5Y CAGR: -68.1%
EPS (Diluted)
$0.00
+101.7% ▲
5Y CAGR: -85.3%
EBITDA
$21K
+104.6% ▲
5Y CAGR: -70.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $44M | $89K | $3M | $1M | $320K |
| YoY Growth | +24.3% | -99.8% | +3782.6% | -61.7% | -75.8% |
| Cost of Revenue | $20M | $15M | $3M | $1M | $264K |
| Gross Profit | $24M | -$15M | $483K | $274K | $56K |
| Gross Margin | 54.5% | -16399.6% | 14.0% | 20.7% | 17.5% |
| R&D Expenses | $0 | $283K | $189K | $50K | $9K |
| SG&A Expenses | $15M | $428K | $482K | $711K | $38K |
| Operating Expenses | $19M | $400K | $672K | $760K | $48K |
| Operating Income | $4M | -$326K | -$189K | -$486K | $8K |
| Operating Margin | 9.2% | -365.5% | -5.4% | -36.7% | 2.6% |
| Interest Expense | $1M | $65K | $56K | $21K | $0 |
| Income Before Tax | $4M | -$328K | -$86K | -$507K | $9K |
| Tax Expense | $1M | $33.1B | $9K | $3K | $0 |
| Net Income | $2M | -$34M | -$81K | -$510K | $9K |
| Net Margin | 5.0% | -37818.6% | -2.3% | -38.5% | 2.8% |
| EPS (Diluted) | $0.12 | $-0.55 | $-0.00 | $-0.01 | $0.00 |
| EBITDA | $4M | -$555K | $29K | -$450K | $21K |
| Shares Outstanding | 19M | 61M | 77M | 85M | 85M |